Amphastar Pharmaceuticals, Inc. vs Solid Biosciences Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Amphastar Pharmaceuticals, Inc. is the larger company by market value: $1.1 B against $713 M for Solid Biosciences Inc., 1.5 times as much (market caps of Oct 28, 2026 for Amphastar Pharmaceuticals, Inc. and Oct 30, 2026 for Solid Biosciences Inc.).
- Amphastar Pharmaceuticals, Inc. made a net profit of $98 M, while Solid Biosciences Inc. made a net loss of $174 M.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Amphastar Pharmaceuticals, Inc. AMPH · #8,923 in the world | Solid Biosciences Inc. SLDB · #11,013 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceutical | Pharmaceutical |
| Founded | — | 2013 |
| Size | ||
| Market cap | $1.1 B | $713 M |
| Revenue | $720 M | — |
| Net income | $98 M▲ best | $-174 M |
| Employees | 1,761 | — |
| Valuation | ||
| P/E ratio | 11.0× | — |
| Price to sales | 1.5× | — |
| Price to book | 1.4× | 4.0× |
| Free cash flow yield | 11.1%▲ best | -22.1% |
| Profitability | ||
| Gross margin | 49.5% | — |
| Operating margin | 19.5% | — |
| Net margin | 13.6% | — |
| Return on equity | 12.9%▲ best | -109.9% |
| Return on invested capital | 9.2% | — |
| Growth | ||
| Revenue growth | -1.6% | — |
| Revenue growth, 3 years a year | 13.0% | — |
| Earnings per share growth | -33.7% | — |
| Financial strength | ||
| Debt to equity | 0.8× | — |
| Cash | ||
| Free cash flow margin | 16.8% | — |
| Shareholder returns | ||
| Shareholder yield | 6.9% | — |
| Strength scores | ||
| Piotroski F-score | 6 of 9 | — |
| Altman Z-score zone | grey | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Amphastar Pharmaceuticals, Inc. or Solid Biosciences Inc.?
Amphastar Pharmaceuticals, Inc. is the larger company by market value: $1.1 B against $713 M for Solid Biosciences Inc., 1.5 times as much (market caps of Oct 28, 2026 for Amphastar Pharmaceuticals, Inc. and Oct 30, 2026 for Solid Biosciences Inc.).
Which makes more money, Amphastar Pharmaceuticals, Inc. or Solid Biosciences Inc.?
Amphastar Pharmaceuticals, Inc. made a net profit of $98 M, while Solid Biosciences Inc. made a net loss of $174 M.
More about Amphastar Pharmaceuticals, Inc.
- Amphastar Pharmaceuticals, Inc.: company page
- Who owns Amphastar Pharmaceuticals, Inc.?
- Amphastar Pharmaceuticals, Inc. market cap history
- Amphastar Pharmaceuticals, Inc. revenue by year
- Is Amphastar Pharmaceuticals, Inc. cheap or expensive?
- Amphastar Pharmaceuticals, Inc. against its peers: ranks and percentiles
More about Solid Biosciences Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.